id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-D-0529-0011,FDA,FDA-2012-D-0529,"Recommended Statement for Over-the-Counter Aspirin-Containing Drug
Products Labeled With Cardiovascular-Related Imagery; Guidance for
Industry; Availability",Notice,Notice of Availability,2017-11-07T05:00:00Z,2017,11,2017-11-07T05:00:00Z,,2017-11-07T15:31:28Z,2017-24192,0,0,0900006482c53e92
FDA-2012-D-0529-0012,FDA,FDA-2012-D-0529,Recommended Statement for Over-the-Counter Aspirin-Containing Drug Products Labeled With Cardiovascular Related Imagery Guidance for Industry,Other,Guidance,2017-11-07T05:00:00Z,2017,11,2017-11-07T05:00:00Z,,2024-11-07T01:10:16Z,,1,0,0900006482c548f3
FDA-2012-D-0529-0007,FDA,FDA-2012-D-0529,Recommended Statement for Over-the-Counter Aspirin-Containing Drug Products Labeled With Cardiovascular Related Imagery,Other,Guidance,2017-01-11T05:00:00Z,2017,1,2017-01-11T05:00:00Z,,2024-11-12T06:18:07Z,,1,0,090000648245ba09
FDA-2012-D-0529-0006,FDA,FDA-2012-D-0529,"Recommended Statement for Over-the-Counter Aspirin-Containing Drug
Products Labeled With Cardiovascular Related Imagery; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2017-01-11T05:00:00Z,2017,1,2017-01-11T05:00:00Z,2017-03-14T03:59:59Z,2017-03-14T01:02:02Z,2017-00374,0,0,090000648245aff6
FDA-2012-D-0529-0005,FDA,FDA-2012-D-0529,"Organ-Specific Warnings: Internal Analgesic, Antipyretic, and
Antirheumatic Drug Products for Over-the-Counter Human Use -
Labeling for Products That Contain Acetaminophen Guidance for Industry",Other,Guidance,2015-11-17T05:00:00Z,2015,11,2015-11-17T05:00:00Z,,2024-11-07T23:32:52Z,,1,0,0900006481d4d801
FDA-2012-D-0529-0004,FDA,FDA-2012-D-0529,"Organ-Specific Warnings: Internal Analgesic, Antipyretic, and
Antirheumatic Drug Products for Overthe-Counter Human Use—Labeling for Products That Contain Acetaminophen; Guidance for
Industry; Availability",Notice,Notice of Availability,2015-11-17T05:00:00Z,2015,11,2015-11-17T05:00:00Z,,2015-11-17T14:30:25Z,2015-29281,0,0,0900006481d4d3e9
FDA-2012-D-0529-0001,FDA,FDA-2012-D-0529,"Draft Guidance for Industry on Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use--- Labeling for Products That Contain Acetaminophen; Availability",Notice,Notice of Availability,2012-07-05T04:00:00Z,2012,7,2012-07-05T04:00:00Z,2012-09-05T03:59:59Z,2015-10-30T19:07:53Z,2012-16244,0,0,090000648107a968
FDA-2012-D-0529-0002,FDA,FDA-2012-D-0529,"Draft Guidance for Industry on Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use--- Labeling for Products That Contain Acetaminophen",Other,Guidance,2012-07-05T04:00:00Z,2012,7,2012-07-05T04:00:00Z,2012-09-05T03:59:59Z,2012-07-05T13:51:59Z,,0,0,090000648107943e